Bryce Point Capital, LLC Revolution Medicines, Inc. Transaction History
Bryce Point Capital, LLC
- $345 Billion
- Q4 2024
A detailed history of Bryce Point Capital, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Bryce Point Capital, LLC holds 18,479 shares of RVMD stock, worth $776,118. This represents 0.23% of its overall portfolio holdings.
Number of Shares
18,479Holding current value
$776,118% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding RVMD
# of Institutions
289Shares Held
167MCall Options Held
260KPut Options Held
620K-
Vanguard Group Inc Valley Forge, PA17.1MShares$718 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$563 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA11.3MShares$475 Million2.58% of portfolio
-
Wellington Management Group LLP Boston, MA10.8MShares$455 Million0.09% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$318 Million3.67% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.68B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...